| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 144.362 | 80 |
| GSM780708 | Untreated after 4 days (C2_1) | 102.362 | 76 |
| GSM780709 | Untreated after 4 days (C3_1) | 92.0586 | 74 |
| GSM780719 | Untreated after 4 days (C1_2) | 153.148 | 81 |
| GSM780720 | Untreated after 4 days (C2_2) | 97.8641 | 75 |
| GSM780721 | Untreated after 4 days (C3_2) | 100.601 | 75 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 99.7252 | 75 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 115.91 | 77 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 127.976 | 79 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 87.8715 | 73 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 107.523 | 76 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 125.319 | 78 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 123.332 | 78 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 98.6621 | 75 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 120.885 | 78 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 131.44 | 79 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 92.4447 | 74 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 115.012 | 77 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 94.7634 | 74 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 115.09 | 77 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 100.793 | 75 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 96.8736 | 75 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 101.986 | 75 |